Patients News | pharmaphorum

News

UCB bags FDA okay for first drug to treat rare disease TK2d

People living with thymidine kinase 2 deficiency (TK2d), a vanishingly rare and often fatal genetic disorder, finally have an approved therapy.

News

Free Wegovy trialled in deprived areas of Scotland

Thousands of people from Scotland's most deprived areas will get free weight-loss jabs in a real-world study to gauge if they can save the NHS money.

News

Medical group advises against leucovorin for autism

The American Academy of Paediatrics has warned against leucovorin as a treatment for autism, citing a lack of evidence on safety and efficacy.

News

"Significant shift" as NICE widens prostate cancer drug use

NICE has changed unpopular guidance on abiraterone for hormone-sensitive prostate cancer after the entry of generics into the UK market.

News

Blue ribbon for prostate cancer awareness

As UK mulls prostate cancer screening, study shows benefit

New data have shown that the balance between the benefits and harms of prostate cancer screening has improved with longer follow-up.

News

Falling flu vaccine sales in US stall CSL's Seqirus spinout

CSL says flu vaccination rates in the US are expected to fall 12% to 14% this year, and have scuppered its plan to spin out its vaccines unit Seqirus.

UCB bags FDA okay for first drug to treat rare disease TK2d

Free Wegovy trialled in deprived areas of Scotland

Medical group advises against leucovorin for autism

"Significant shift" as NICE widens prostate cancer drug use

As UK mulls prostate cancer screening, study shows benefit

Falling flu vaccine sales in US stall CSL's Seqirus spinout

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

News

Editor's Picks